A detailed history of Callan Capital, LLC transactions in Inogen Inc stock. As of the latest transaction made, Callan Capital, LLC holds 20,611 shares of INGN stock, worth $200,132. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,611
Previous 38,194 46.04%
Holding current value
$200,132
Previous $310,000 35.81%
% of portfolio
0.01%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$7.67 - $12.98 $134,861 - $228,227
-17,583 Reduced 46.04%
20,611 $199,000
Q2 2024

Oct 22, 2024

BUY
$6.3 - $8.95 $110,772 - $157,367
17,583 Added 85.31%
38,194 $310,000
Q1 2024

Oct 22, 2024

BUY
$5.26 - $10.15 $92,486 - $178,467
17,583 Added 85.31%
38,194 $308,000
Q1 2023

May 08, 2023

BUY
$11.88 - $26.0 $244,858 - $535,886
20,611 New
20,611 $257,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $222M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Callan Capital, LLC Portfolio

Follow Callan Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.